The ability to create health information technology tools is happening much faster than the ability to figure out what to do with them, explained Peter Paul Yu, MD, FASCO, FACP, physician-in-chief, Hartford HealthCare Cancer Center.
The ability to create health information technology tools is happening much faster than the ability to figure out what to do with them, explained Peter Paul Yu, MD, FASCO, FACP, physician-in-chief, Hartford HealthCare Cancer Center.
Transcript
How have health technologies helped enhance high-quality cancer care and improve outcomes for patients?
So, the great challenge we’ve always faced is how do we keep pace with the new technologies that are coming down the pipe? Because we’re getting so good at developing new technologies, whether it’s informatics or it’s precision medicine or new drug therapies or diagnostics. Our ability to create these new tools is much faster than our ability to figure out what to do with it, because when you want to measure outcomes improvement, it requires acquisition of the technology, which has certain expense to it. It requires learning how to use it properly, adapting it to its use, and then measuring the outcomes.
There may be many intermediary steps between the technology and actually the outcomes measures, so it’s a real difficult question to answer: how have these improved our outcomes? It’s really that lack of ability to measure adequately that’s slowing us down more than anything else at this time.
Having said that, I think we are seeing real progress with the use of information technology. I think, without a question, if you ask most physicians, I think, would they rather go back to paper charts? The answer would probably be "no." If you asked patients, would you like to go back to the age where you could not get a patient portal? Find out your lab tests? I mean you always want more, but would you want to go back to the point where you had nothing? People would say "no, that’s not a good idea either."
So, I think that we are frustrated with how slow it goes, but that tends to make us not realize how far we’ve gone and where we used to be just a short while ago.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More